FDA Inspection
MEGHMANI LLPMEGHMANI LLP – FDA Inspection, Feb 3, 2026
Record Details
This FDA Inspection record concerns MEGHMANI LLP, with an inspection on February 3, 2026, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · d83b1a38-e84d-4eef-b35d-3609537c35c1
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1300978
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
8- 21 CFR 211.105(a)Identification of containers, lines, equipment
- 21 CFR 211.160(b)(3)Drug product sample
- 21 CFR 211.22(d)Procedures not in writing, fully followed
- 21 CFR 211.42(c)(2)Rejected Material Area
- 21 CFR 211.56(a)Sanitation--buildings not clean, free of infestation
- 21 CFR 211.58Buildings not maintained in good state of repair
- 21 CFR 211.63Equipment Design, Size and Location
- 21 CFR 211.80(b)Handling and Storage to Prevent Contamination
Full citation text and observation details available on the Dashboard.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.